Compositions for reducing bacterial carriage and CNS invasion and methods of using same

Details for Australian Patent Application No. 2004289295 (hide)

Owner The UAB Research Foundation

Inventors Briles, David E.; Van Ginkel, Frederik W.; Watt, James M.

Agent Griffith Hack

Pub. Number AU-B-2004289295

PCT Pub. Number WO2005/046721

Priority 60/518,799 10.11.03 US

Filing date 10 November 2004

Wipo publication date 26 May 2005

Acceptance publication date 12 August 2010

International Classifications

C07K 16/12 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from bacteria

A61K 39/09 (2006.01) Medicinal preparations containing antigens or antibodies - Streptococcus

C07K 16/40 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against enzymes

C12N 9/24 (2006.01) Enzymes, e.g. ligases (6.) - acting on glycosyl compounds (3.2)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

1 June 2006 PCT application entered the National Phase

  PCT publication WO2005/046721 Priority application(s): WO2005/046721

13 May 2010 Alteration of Name

  The name of the applicant has been altered to The UAB Research Foundation

12 August 2010 Application Accepted

  Published as AU-B-2004289295

9 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004289297-Compositions, kits, and methods for the treatment of conditions associated with elevated cholesterol levels

2004289291-Expandable medical device with beneficial agent matrix formed by a multi solvent system